日本市场个股详情
4516 日本新药
- 4388.0
- +116.0+2.72%
延时20分钟行情已收盘 11/28 15:30 (东京)
3082.64亿总市值11.43市盈率(静)
4414.0最高价4277.0最低价44.23万股成交量4305.0今开4272.0昨收19.29亿成交额5330.052周最高0.71%换手率7025.15万总股本2694.052周最低386.72每股收益TTM2739.92亿流通值10360.0历史最高11.43市盈率(静)6244.11万流通股489.0历史最低383.82每股收益(静)3.21%振幅124.00股息TTM1.26市净率100股每手2.83%股息率TTM
关于日本新药公司
Nippon Shinyaku Co Ltd是一家专业和仿制药制造公司。Nippon的研发活动包括专注于药物、营养品、药物种子的安全性和药代动力学、基因组药物发现和核酸药物。该公司还开发健康食品原料、防腐剂、蛋白制剂和香料。Nippon将并购投资视为其业务增长战略的潜在组成部分，以扩大其研究、开发、制造和营销能力。
公司介绍
公司代码4516
公司名称日本新药
成立日期1919-10-01
所属市场东证Prime
员工数量2213
年结日03-31
公司地址14, Nishinosho-Monguchi-cho Kisshoin, Minami-ku
邮编601-8550
电话075-321-1111
董事高管
- 姓名
- 职务
- 年薪
- Takanori Edamitsu
- Director and General Manager, Business Management and Sustainability
- --
- Kazuchika Takagaki
- Director, General Manager, Research and Development and Head of Research and Development Division
- --
- Hitoshi Ishizawa
- Director, General Manager, Functional Food and Head of Functional Food Division
- --
- Hitomi Kimura
- Director and General Manager, Resource Procurement, Production and Assurance
- --
- Takashi Takaya
- Director and General Manager, Personnel, General Affairs, Risk Management, Compliance and Digital Transformation
- --
- Shouzou Sano
- Director, Managing Director, General Manager, Sales and Marketing and Head of Sales and Marketing Division
- --
- Shigenobu Maekawa
- Chairman of the Board
- --
- Toru Nakai
- Director and President
- --
- Yukari Kobayashi
- Independent Director
- --
- Dr. Yoshinao Wada, PhD
- Independent Director
- --
- Dr. Mayumi Nishi
- Independent Director
- --
- Miyuki Sakurai
- Independent Director
- --
分析
目标价预测
暂无数据
热议
日股
综合热度
股票代码
最新价
涨跌幅
暂无数据